Indeed, from a cardiological point of view, diabetes is a cardiovascular disease [4]
Semaglutide and Wegovy mimic a hormone that regulates appetite and blood sugar, while Zepbound targets two hormones for potentially greater weight loss
I feel your risk of low blood sugar is actually lower when youre taking a GLP-1 because you eventually need less insulin. SGLT-2s increase the risk of DKA and dehydration The biggest challenge to using SGLT-2 inhibitors in type 1 diabetes is the risk for DKA, including a rare type called euglycemic DKA (EDKA)
Fat storage shifts from the hips and thighs toward the abdominal region
They can also stimulate one or more DNA repair pathways, prevent apoptotic cell death, modulate redox sensitive genes, and display an anti- inflammatory response as well as promoting tissue regeneration (168)
Experts believe the buzz around Melanotan-II is largely being driven by social media Advertisement Experts believe the buzz around Melanotan-II is largely being driven by social media